These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 11096432)
1. Vancomycin Use in a Brazilian University Hospital: Comparison With Hospital Infection Control Practices Advisory Committee Guidelines. Couto HG; Leles CC; Lima HV; Assunção VF; Ribas RM; AD Filho; Gontijo PP Braz J Infect Dis; 1999 Aug; 3(4):139-143. PubMed ID: 11096432 [TBL] [Abstract][Full Text] [Related]
2. A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines. Hospital Infection Control Practice Advisory Committee. Salemi C; Becker L; Morrissey R; Warmington J Clin Perform Qual Health Care; 1998; 6(1):12-6. PubMed ID: 10177043 [TBL] [Abstract][Full Text] [Related]
4. Vancomycin use in 2 Ontario tertiary care hospitals: a survey. Kwan T; Lin F; Ngai B; Loeb M Clin Invest Med; 1999 Dec; 22(6):256-64. PubMed ID: 10664867 [TBL] [Abstract][Full Text] [Related]
5. Vancomycin use in a university medical center: effect of a vancomycin continuation form. Evans ME; Millheim ET; Rapp RP Infect Control Hosp Epidemiol; 1999 Jun; 20(6):417-20. PubMed ID: 10395144 [TBL] [Abstract][Full Text] [Related]
6. Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit. Thorburn K; Taylor N; Saladi SM; van Saene HK Clin Microbiol Infect; 2006 Jan; 12(1):35-42. PubMed ID: 16460544 [TBL] [Abstract][Full Text] [Related]
7. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Evans ME; Kortas KJ Infect Control Hosp Epidemiol; 1996 Jun; 17(6):356-9. PubMed ID: 8805065 [TBL] [Abstract][Full Text] [Related]
8. Preventing the Spread of Vancomycin Resistance--A Report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period and public meeting--CDC. Notice. Fed Regist; 1994 May; 59(94):25758-63. PubMed ID: 10136017 [TBL] [Abstract][Full Text] [Related]
9. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Wang Z; Cao B; Liu YM; Gu L; Wang C Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138 [TBL] [Abstract][Full Text] [Related]
12. Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital. Wang JT; Chen YC; Chang SC; Chen ML; Pan HJ; Chang YY; Sun CC; Wang LH; Wang SH; Lin HC; Chien SF; Tseng MS J Hosp Infect; 2004 Oct; 58(2):97-103. PubMed ID: 15474179 [TBL] [Abstract][Full Text] [Related]
13. Vancomycin use in a Brazilian teaching hospital: comparison with the Hospital Infection Controlpractices Advisory Committee Guidelines (HICPAC). Melo DO; Ribeiro E Braz J Infect Dis; 2009 Jun; 13(3):161-4. PubMed ID: 20191189 [TBL] [Abstract][Full Text] [Related]
14. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250 [TBL] [Abstract][Full Text] [Related]
15. A targeted review of vancomycin use. Piquette RK Can J Hosp Pharm; 1991 Apr; 44(2):83-7. PubMed ID: 10111726 [TBL] [Abstract][Full Text] [Related]
16. Assessment of vancomycin use in chronic haemodialysis patients: room for improvement. Zvonar R; Natarajan S; Edwards C; Roth V Nephrol Dial Transplant; 2008 Nov; 23(11):3690-5. PubMed ID: 18565979 [TBL] [Abstract][Full Text] [Related]
17. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970 [TBL] [Abstract][Full Text] [Related]
18. Severe invasive community-associated methicillin-resistant Staphylococcus aureus infections in previously healthy children. Creel AM; Durham SH; Benner KW; Alten JA; Winkler MK Pediatr Crit Care Med; 2009 May; 10(3):323-7. PubMed ID: 19307811 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Furtado GH; Mendes RE; Pignatari AC; Wey SB; Medeiros EA Am J Infect Control; 2006 Sep; 34(7):447-51. PubMed ID: 16945692 [TBL] [Abstract][Full Text] [Related]
20. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]